Carregant...
Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
Many patients with chronic kidney disease (CKD) receive anticoagulation or antiplatelet therapy due to atrial fibrillation, coronary artery disease, thromboembolic disease, or peripheral artery disease. The treatment usually includes vitamin K antagonists (VKAs) and/or platelet aggregation inhibitor...
Guardat en:
| Publicat a: | Int J Nephrol Renovasc Dis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5473496/ https://ncbi.nlm.nih.gov/pubmed/28652799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S105771 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|